Systematic review of 8 studies (4 meta-analysed; 470 patients) of switching biologics in CRSwNP: SNOT-22 improved by a mean 71.4% after switching, success rates ranged 59.6% to 100% (average 79.2%); switching was mostly for poor symptom control (59.7%).
Meta-analysisn = 470
Aljubran et al. Therapeutic outcomes of biologic switching in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis